Gallium 68 P15 041

Drug Profile

Gallium 68 P15 041

Alternative Names: [68Ga]P15-041

Latest Information Update: 05 Aug 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Five Eleven Pharma
  • Class Radiopharmaceutical diagnostics
  • Mechanism of Action Emission-computed tomography enhancers; Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase 0 Bone metastases

Most Recent Events

  • 25 Jul 2016 Phase-0 for Bone metastases (Diagnosis) in USA (Parenteral) (NCT02826382)
  • 19 Jul 2016 Five Eleven Pharma plans a phase 0 trial in Bone metastases (Diagnosis) in USA (NCT02826382)
  • 01 Jul 2016 Preclinical trials in Bone metastases (Diagnosis) in USA (Parenteral) before July 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top